# Development and Validation of Models to Predict Functional Cure in Patients With CHB After Peg-IFN Based Therapy

> **NCT06196632** · — · UNKNOWN · sponsor: **Qilu Hospital of Shandong University** · enrollment: 1000 (estimated)

## Conditions studied

- Hepatitis B, Chronic

## Interventions

- **DRUG:** Peginterferon-α; Nucleoside analogs

## Key facts

- **NCT ID:** NCT06196632
- **Lead sponsor:** Qilu Hospital of Shandong University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-01-06
- **Primary completion:** 2024-07-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2024-02-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06196632

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06196632, "Development and Validation of Models to Predict Functional Cure in Patients With CHB After Peg-IFN Based Therapy". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT06196632. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*